Cost effectiveness of hepatitis C direct acting agents

By sjmartinez • April 26, 2024

Shetty A, Lee M, Valenzuela J, Saab S. Cost effectiveness of hepatitis C direct acting agents. Expert Rev Pharmacoecon Outcomes Res. 2024 Apr 26. doi: 10.1080/14737167.2024.2348053. Epub ahead of print. PMID: 38665122.

Tags: Antiviral Therapy, Cost effectiveness, Digestive Diseases, Direct acting agents, Hepatitis C, Publications

Statins in chronic liver disease: review of literature and future role

Pham N, Benhammou JN. Statins in chronic liver disease: review of literature and future role. Semin Liver Dis. 2024 May 3. doi: 10.1055/a-2319-0694. Epub ahead[...]

Pragmatic strategies to address health disparities along the continuum of care in chronic liver disease

Brahmania M, Rogal S, Serper M, Patel A, Goldberg D, Mathur A, Wilder J, Vittorio J, Yeoman A, Rich NE, Lazo M, Kardashian A, Asrani[...]

Author Correction: Cost-effective methylome sequencing of cell-free DNA for accurately detecting and locating cancer

Stackpole ML, Zeng W, Li S, Liu CC, Zhou Y, He S, Yeh A, Wang Z, Sun F, Li Q, Yuan Z, Yildirim A, Chen[...]